Prompt discontinuation of the suspected drug is critical for recovery. Drug-induced immune hemolytic anemia (DIIHA) should be investigated in suspected cases of warm autoimmune hemolytic anemia (warm ...

The Reagan-Udall foundation was named for President Ronald Reagan and Congressman Morris “Mo” Udall from Arizona, each of whom had an incurable neurodegenerative disease. The Reagan-Udall Foundation ...

Interim biomarker data from the first 4 patients showed lower creatine kinase levels by week 10, with 3 of the 4 also showing Glc4 reductions. Aro Biotherapeutics announced positive interim results ...

Wild-type ATTR-CM comprised 76% of cardiac amyloidosis cases, with prevalence highest in Asia and lowest in North America. Cardiac amyloidosis (CA) is present in approximately 10% of patients with ...

New research suggests that caffeine could help treat fatigue, among the most troubling symptoms of multiple sclerosis (MS). According to the results of a small study published in the February 2026 ...

Responses deepened over time, with most partial responses converting to complete responses by the end of induction. The addition of the Bruton tyrosine kinase inhibitor ibrutinib to rituximab, ...

Normalization of C1 inhibitor activity and C4 levels supported reclassification to type 3 disease after years of presumed type 2 angioedema. Reclassification of hereditary angioedema (HAE) subtype ...

Responses were consistent across adverse cytogenetic and molecular subgroups, although TP53 alterations remained prognostically adverse. A 15-day course of venetoclax combined with azacitidine ...

The rarity of generalized pustular psoriasis is associated with limited clinical experience and thus creates difficulty in the assessment of therapeutic proposals. The Psoriasis Working Group has ...

If approved, CAM2029 could offer a self-administered alternative to intramuscular long-acting somatostatin analogs, with the potential to reduce treatment burden. The US Food and Drug Administration ...

Aerosolized porcine brain tissue may have included synaptic vesicles containing synaptophysin and GAP43, leading to inhalation exposure. Reinvestigation of a mysterious outbreak of occupational ...

Fenebrutinib demonstrated noninferiority to ocrelizumab in patients with PPMS, a population with limited treatment options. Genentech has reported that fenebrutinib reduced relapse rates in relapsing ...